Avantor, Inc. (NYSE:AVTR) Shares Sold by First Hawaiian Bank

First Hawaiian Bank reduced its stake in shares of Avantor, Inc. (NYSE:AVTR) by 6.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 85,364 shares of the company’s stock after selling 6,218 shares during the period. First Hawaiian Bank’s holdings in Avantor were worth $1,810,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Fifth Third Bancorp lifted its position in Avantor by 125.3% during the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after purchasing an additional 694 shares during the period. Oak Thistle LLC purchased a new position in Avantor in the fourth quarter valued at $339,000. Arizona State Retirement System increased its holdings in Avantor by 0.9% in the fourth quarter. Arizona State Retirement System now owns 185,769 shares of the company’s stock valued at $4,241,000 after buying an additional 1,585 shares in the last quarter. DekaBank Deutsche Girozentrale increased its holdings in Avantor by 3.8% in the fourth quarter. DekaBank Deutsche Girozentrale now owns 162,451 shares of the company’s stock valued at $3,724,000 after buying an additional 5,997 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. increased its holdings in Avantor by 8.4% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 2,508,557 shares of the company’s stock valued at $57,269,000 after buying an additional 194,031 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

AVTR has been the subject of a number of recent analyst reports. Barclays lifted their price objective on shares of Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Morgan Stanley lifted their price objective on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a report on Monday, July 29th. TD Cowen lifted their price objective on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday, July 29th. Evercore ISI reduced their price target on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 2nd. Finally, Robert W. Baird lifted their price objective on Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Avantor presently has an average rating of “Moderate Buy” and an average price target of $27.21.

Insider Buying and Selling at Avantor

In other news, insider Christophe Couturier 10,000 shares of Avantor stock in a transaction dated Tuesday, July 30th. The was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.50% of the stock is currently owned by corporate insiders.

Avantor Trading Down 2.5 %

NYSE AVTR traded down $0.64 during trading hours on Monday, reaching $24.96. The company had a trading volume of 10,857,442 shares, compared to its average volume of 7,129,846. The stock has a 50-day moving average of $22.59 and a 200 day moving average of $23.81. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $28.00. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The stock has a market capitalization of $16.97 billion, a P/E ratio of 65.64, a price-to-earnings-growth ratio of 2.71 and a beta of 1.32.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.